Patent · US Expired

Antibodies specific for Fkhsf gene products

US6683160B1 · kind B1 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2000
Grant dateJan 27, 2004
Priority date
Expiry dateMar 13, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Assays that are based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), may be used for identifying numerous molecules that modulate the immune system. Molecules that specifically bind to an Fkhsf polypeptide are also provided as useful, such as, for modulating the biological activities of Fkhsf. In particular, antibodies that are specific for Fkhsf polypeptide are provided for uses such as for detecting the expression of an Fkhsf polypeptide in cells, isolating an Fkhsf polypeptide, and modulating the activity of an Fkhsf polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.